422 related articles for article (PubMed ID: 26182758)
1. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.
Larsson P; Wijkström H; Thorstenson A; Adolfsson J; Norming U; Wiklund P; Onelöv E; Steineck G
Scand J Urol Nephrol; 2003; 37(3):195-201. PubMed ID: 12775276
[TBL] [Abstract][Full Text] [Related]
4. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
7. Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
Koyuncuer A
Asian Pac J Cancer Prev; 2015; 16(7):2871-7. PubMed ID: 25854375
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).
Jones TD; Cheng L
Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological characteristics and outcome of upper urinary tract urothelial carcinoma presenting to a tertiary care urology unit in Sri Lanka.
Jayarajah U; Fernando MH; Herath KB; Kuruppu SN; Wickramanayaka UL; Fernando IU; de Silva VC; Goonewardena SAS
Ceylon Med J; 2018 Sep; 63(3):129-132. PubMed ID: 30415517
[TBL] [Abstract][Full Text] [Related]
11. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
Mamoon N; Iqbal MA; Jamal S; Luqman M
J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
[TBL] [Abstract][Full Text] [Related]
12. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
[TBL] [Abstract][Full Text] [Related]
13. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Hentschel AE; van Rhijn BWG; Bründl J; Compérat EM; Plass K; Rodríguez O; Henríquez JDS; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Scavarda-Lamberti A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Cohen D; Lunelli L; Cussenot O; Sheikh SE; Volanis D; Coté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Babjuk M; van der Kwast TH; Sylvester RJ
Urol Oncol; 2020 May; 38(5):440-448. PubMed ID: 31704141
[TBL] [Abstract][Full Text] [Related]
14. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
Vaidya S; Lakhey M; K C S; Hirachand S
JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
[TBL] [Abstract][Full Text] [Related]
15. Transitional cell carcinomas of the urinary bladder. A histopathological study.
Ahmed Z; Muzaffer S; Khan M; Kayani N; Pervez S; Husseini AS; Hasan SH
J Pak Med Assoc; 2002 Sep; 52(9):396-8. PubMed ID: 12532572
[TBL] [Abstract][Full Text] [Related]
16. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.
Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
Br J Urol; 1996 Aug; 78(2):209-12. PubMed ID: 8813915
[TBL] [Abstract][Full Text] [Related]
17. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
18. Frequency and predictors of recurrence of bladder tumour on first check cystoscopy - a tertiary care hospital experience.
Farhan M; Nazim SM; Ahmed J; Ather MH
J Pak Med Assoc; 2016 Oct; 66(Suppl 3)(10):S125-S130. PubMed ID: 27895377
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression.
Vardar E; Gunlusoy B; Minareci S; Postaci H; Ayder AR
Urol Int; 2006; 77(1):27-33. PubMed ID: 16825812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]